CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

  • ID: 4142710
  • Report
  • Region: Russia
  • 215 pages
  • GlobalData
1 of 3
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

Summary

The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Russia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

In 2016, Russia population was approximately at 146.9 million. The government of Russia has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. Russia’s pharmaceutical market is one of the fastest growing in the world, and the largest in Central and Eastern Europe. Its value was RUB1.12 trillion in 2015 and increased at an Annual Growth Rate (AGR) of 7.8% in terms of rubles to RUB1.21 trillion in 2016. The market is expected to reach RUB2.22 trillion in 2021 at a CAGR of 12.9%.

Based on the 2016 currency exchange rate of RUB1 to $0.0165, the market is expected to reach $36.61 billion by 2021. The Russian medical device market was valued at $5.0 billion in 2009 and is one of the most stable industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $6.7 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $8.5 billion in 2021. The segments expected to experience high growth are ophthalmic devices, wound care management, CVD, orthopedic devices and diagnostic imaging.

These positive trends can primarily be attributed to:
  • An increasing elderly population in Russia, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pharmstandard)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Russian healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to:
  • Develop business strategies by understanding the trends shaping and driving the Russian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Russian healthcare market.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Table of Contents

2 Executive Summary

3 Introduction
3.1 Report Guidance

4 Overview of the Pharmaceutical and Medical Device Markets
4.1 Pharmaceutical Market
4.1.1 Market Overview
4.1.2 Pharmaceutical Exports and Imports
4.1.3 Supply Channels
4.1.4 Market Segments
4.1.5 Overview of Top Five Disease Areas
4.1.6 Major Players
4.2 Medical Device Market
4.2.1 Market Overview
4.2.2 Overview of Top Five Segments
4.2.3 Major Players
4.3 Market Drivers and Barriers
4.3.1 Drivers
4.3.2 Barriers

5 Market Access
5.1 Reimbursement and Payer Landscape
5.1.1 Overview of Healthcare System
5.1.2 Reimbursement Process
5.1.3 Overview of Insurance Providers
5.1.4 Patient Share in Healthcare Spending
5.1.5 Price Trend in Healthcare Services
5.1.6 Pricing Policies
5.2 Regulatory Landscape
5.2.1 Overview of Regulatory Agencies
5.2.2 Market Authorization Procedure for Pharmaceutical Products
5.2.3 Market Authorization Procedure for Medical Devices
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
5.2.5 Licensing Process for Pharmaceutical Exports and Imports
5.2.6 Intellectual Property Rights
5.2.7 Clinical Trial Regulations
5.2.8 Pharmaceutical Advertising Regulations
5.2.9 Labeling and Packaging Regulations

6 Country Analysis
6.1 Political Environment
6.1.1 Political Structure
6.1.2 Analysis of the Current Political Environment
6.1.3 Healthcare Policy Initiatives
6.2 Economic Landscape
6.3 Economic Indicators
6.3.1 Gross Domestic Product
6.3.2 Gross National Income
6.3.3 Inflation
6.3.4 Currency Exchange Rate
6.3.5 Foreign Direct Investment
6.3.6 Foreign Exchange Reserves
6.3.7 Trade Balance
6.3.8 General Government Structural Balance
6.3.9 General Government Gross Debt
6.3.10 Major Industries
6.4 Demographics
6.4.1 Population
6.4.2 Education and Literacy
6.4.3 Employment
6.4.4 Disease Burden
6.5 Healthcare Infrastructure
6.5.1 Healthcare Facilities
6.5.2 Healthcare Parameters
6.5.3 Environmental Health
6.5.4 Healthcare Personnel
6.6 Healthcare Expenditure
6.6.1 Overview
6.6.2 Public-Private Sector Share
6.6.3 Major Components of Healthcare Spending
6.6.4 Spending in Science and Technology Research and Development
6.7 Trade Associations
6.7.1 Association of Russian Pharmaceutical Manufacturers
6.7.2 Association of International Pharmaceutical Manufacturers
6.7.3 Russian Association of Pharmaceutical Marketing
6.8 Trade Fairs

7 Opportunities and Challenges
7.1 Opportunities
7.2 Challenges

8 Appendix
8.1 Abbreviations
8.2 Bibliography
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Forecasts
8.3.4 Expert Panel
8.4 Contact
8.5 Disclaimer

List of Tables
Table 1: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2016
Table 2: Pharmaceutical Market, Russia, Revenue Forecast ($bn), 2017-2021
Table 3: Pharmaceutical Market, Russia, Pharmaceutical Exports and Imports ($bn), 2009-2016
Table 4: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
Table 5: Pharmaceutical Market, Novartis, Planned Filings, 2017-2021
Table 6: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
Table 7: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2016
Table 8: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
Table 9: Pharmaceutical Market,Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016
Table 10: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017
Table 11: Medical Device Market, Russia, Revenue ($bn), 2009-2016
Table 12: Medical Device Market, Russia, Revenue Forecast ($bn), 2017-2021
Table 13: Medical Device Market, Russia, Revenue by Segment ($m), 2016
Table 14: Ophthalmic Devices Market, Russia, Revenue ($m), 2009-2016
Table 15: Ophthalmic Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 16: Wound Care Management Market, Russia, Revenue ($m), 2009-2016
Table 17: Wound Care Management Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2012
Table 18: Cardiovascular Devices Market, Russia, Revenue ($m), 2009-2016
Table 19: Cardiovascular Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 20: Orthopedic Devices Market, Russia, Revenue of Major Players ($m), 2009-2016
Table 21: Orthopedic Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 22: Diagnostic Imaging Market, Russia, Revenue ($m), 2009-2016
Table 23: Diagnostic Imaging Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 24: Medical Device Market, Russia, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 25: Medical Device Market,Medtronic, Major Products, 2016
Table 26: Baxter International, Global, Major Products, 2016
Table 27: Roche, Global,Major Products, 2015
Table 28: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016
Table 29: Healthcare Spending, Russia, Out-of-Pocket Expenditure (%), 2009-2015
Table 30: Medical Equipment Classification, Russia, 2016
Table 31: Medical Equipment Classification Based on Level of Risk, 2016
Table 32: Economic Indicators, Russia, Gross Domestic Product per Capita ($), 2009-2016
Table 33: Economic Indicators, Russia, Gross Domestic Product per Capita Forecast ($), 2017-2021
Table 34: Economic Indicators, Russia, Gross Domestic Product Annual Growth (%), 2009-2016
Table 35: Economic Indicators, Russia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
Table 36: Economic Indicators, Russia, Gross National Income per Capita ($), 2009-2016
Table 37: Economic Indicators, Russia, Average Consumer Price Index, 2009-2016
Table 38: Economic Indicators, Russia, Average Consumer Price Annual Change (%), 2009-2016
Table 39: Economic Indicators, Russia, Currency Exchange Rate (RUB per $), 2009-2016
Table 40: Economic Indicators, Russia, Foreign Direct Investment ($bn), 2009-2016
Table 41: Economic Indicators, Russia, Foreign Exchange Reserves ($bn), 2009-2016
Table 42: Economic Indicators, Russia, Imports of Goods and Services ($bn), 2009-2015
Table 43: Economic Indicators, Russia, Exports of Goods and Services ($bn), 2009-2015
Table 44: Economic Indicators, Russia, Government Structural Balance ($bn), 2009-2016
Table 45: Economic Indicators, Russia, General Government Gross Debt as a Percentage of GDP (%), 2009-2016
Table 46: Economic Indicators, Russia, Major Industries by Revenue Share (%), 2015
Table 47: Demographics, Russia, Population (million) , 2009-2021
Table 48: Demographics, Russia, Fertility rate (children/woman), 1989-2010
Table 49: Demographics, Russia, Urban-Rural Population Share (%), 2009-2016
Table 50: Demographics, Russia, Urban-Rural Population Share Forecast (%), 2017-2021
Table 51: Demographics, Russia, Population Distribution by Age Group (%), 2009-2016
Table 52: Demographics, Russia, Population Distribution by Age Group Forecast (%), 2017-2021
Table 53: Demographics, Russia, Births (per 1,000 population), 2009-2016
Table 54: Demographics, Russia, Mortality (per 1,000 population), 2009-2016
Table 55: Demographics, Russia, Major Causes of Mortality, 2015
Table 56: Demographics, Russia, Infant Mortality (per 1,000 live births), 2009-2016
Table 57: Demographics, Russia, Immunization Rate (%), 2009-2016
Table 58: Demographics, Russia, Major Causes of Male Mortality (per 100,000 population), 2015
Table 59: Demographics, Russia, Major Causes of Female Mortality (per 100,000 population), 2015
Table 60: Demographics, Russia, Gender Ratio (M/F), 2009-2015
Table 61: Demographics, Russia, Life Expectancy at Birth (years), 2009-2016
Table 62: Demographics, Russia, Enrolment by Level of Education (‘000), 2009-2015
Table 63: Demographics, Russia, Unemployment Rate (%), 2009-2015
Table 64: Demographics, Russia, Distribution of Employment by Industry(%), 2015
Table 65: Demographics, Russia, Morbidity (‘000), 2015
Table 66: Demographics, Russia, Disability-Adjusted Life Years by Major Disease (‘000), 2012
Table 67: Healthcare Infrastructure, Russia, Number of Hospitals (‘000), 2009-2015
Table 68: Healthcare Infrastructure, Russia, Number of Outpatient Clinics (‘000), 2009-2015
Table 69: Healthcare Infrastructure, Russia, Public and Private Hospitals, 2009-2015
Table 70: Healthcare Infrastructure, Russia, Hospital Beds by Specialization (‘000), 2014
Table 71: Healthcare Infrastructure, Russia, Diagnostic Equipment (per million population), 2009-2015
Table 72: Healthcare Infrastructure, Russia, Hospital Beds (per 10,000 population), 2009-2015
Table 73: Healthcare Infrastructure, Russia, Doctors (per 10,000 population), 2009-2015
Table 74: Healthcare Infrastructure, Russia, Doctors by Specialization (‘000), 2014
Table 75: Healthcare Infrastructure, Russia, PM2.5 (µg per m3), 2009-2015
Table 76: Healthcare Infrastructure, Russia, CO2 Emissions (million metric tons), 2009-2015
Table 77: Healthcare Infrastructure, Russia, Healthcare Personnel (‘000), 2014
Table 78: Healthcare Expenditure, Russia, Healthcare Expenditure as a Percentage of GDP (%), 2009-2015
Table 79: Healthcare Expenditure, Russia, Public-Private Share (%), 2009-2015
Table 80: Healthcare Expenditure, Russia, R&D Expenditure as a Percentage of GDP (%), 2009-2015
Table 81: Healthcare Expenditure, Russia, Major Healthcare Trade Fairs, 2017

List of Figures
Figure 1: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2021
Figure 2: Medical Device Market, Russia, Revenue ($bn), 2009-2021
Figure 3: Country Profile, Russia, 2017
Figure 4: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2016
Figure 5: Pharmaceutical Market, Russia, Revenue Forecast ($bn), 2017-2021
Figure 6: Pharmaceutical Market, Russia, Pharmaceutical Exports and Imports ($bn), 2009-2016
Figure 7: Medical Device Market, Russia, Revenue ($bn), 2009-2016
Figure 8: Medical Device Market, Russia, Revenue Forecast ($bn), 2017-2021
Figure 9: Medical Device Market, Russia, Revenue by Segment ($m), 2016
Figure 10: Ophthalmic Devices Market, Russia, Revenue ($m), 2009-2016
Figure 11: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015
Figure 12: Wound Care Management Market, Russia, Revenue ($m), 2009-2016
Figure 13: Wound Care Management Market, Russia, Market Share of Major Players (%), 2012
Figure 14: Cardiovascular Devices Market, Russia, Revenue ($m), 2009-2016
Figure 15: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2015
Figure 16: Orthopedic Devices Market, Russia, Revenue ($m), 2009-2016
Figure 17: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2015
Figure 18: Diagnostic Imaging Market, Russia, Revenue ($m), 2009-2016
Figure 19: Diagnostic Imaging Market, Russia, Market Share of Major Companies (%), 2015
Figure 20: Medical Device Market, Russia, Revenue of Major Companies ($m), 2015
Figure 21: Healthcare Market, Russia, Drivers and Barriers, 2017
Figure 22: Market Access, Russia, Procedure for Inclusion of Drugs in Reimbursement Lists, 2017
Figure 23: Healthcare Spending, Russia, Out-of-Pocket Expenditure (%), 2009-2015
Figure 24: Market Access, Russia, Step-down Approach for Generics and Biosimilars Price Calculation, 2017
Figure 25: Market Access, Russia, Overview of Medicines Market Regulation, 2017
Figure 26: Market Access, Russia, Drug Registration Procedure, 2017
Figure 27: Market Access, Russia, Drug Registration Procedure based on Clinical Trials, 2017
Figure 28: Market Access, Russia, GMP Inspection Procedure, 2017
Figure 29: Economic Indicators, Russia, Gross Domestic Product Per Capita ($), 2009-2016
Figure 30: Economic Indicators, Russia, Gross Domestic Product per Capita Forecast ($), 2017-2021
Figure 31: Economic Indicators, Russia, Gross Domestic Product Annual Growth (%), 2009-2016
Figure 32: Economic Indicators, Russia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
Figure 33: Economic Indicators, Russia, Gross National Income per Capita ($), 2009-2016
Figure 34: Economic Indicators, Russia, Average Consumer Price Index, 2009-2016
Figure 35: Economic Indicators, Russia, Average Consumer Price Annual Change (%), 2009-2016
Figure 36: Economic Indicators, Russia, Currency Exchange Rate ($/RUB) 2009-2016
Figure 37: Economic Indicators, Russia, Foreign Direct Investment ($bn), 2009-2016
Figure 38: Economic Indicators, Russia, Foreign Exchange Reserves ($bn), 2009-2016
Figure 39: Economic Indicators, Russia, Imports of Goods and Services ($bn), 2009-2015
Figure 40: Economic Indicators, Russia, Exports of Goods and Services ($bn), 2009-2015
Figure 41: Economic Indicators, Russia, Government Structural Balance ($bn), 2009-2016
Figure 42: Economic Indicators, Russia, General Government Gross Debt as a Percentage of GDP (%), 2009-2016
Figure 43: Economic Indicators, Russia, Major Industries by Revenue Share (%), 2015
Figure 44: Demographics, Russia, Population (million) , 2009-2021
Figure 45: Demographics, Russia, Fertility rate (children/woman), 1989-2010
Figure 46: Demographics, Russia, Urban-Rural Population Share (%), 2009-2016
Figure 47: Demographics, Russia, Urban-Rural Population Share Forecast (%), 2017-2021
Figure 48: Demographics, Russia, Population Distribution by Age Group (%), 2009-2016
Figure 49: Demographics, Russia, Population Distribution by Age Group Forecast (%), 2017-2021
Figure 50: Demographics, Russia, Births (per 1,000 population), 2009-2016
Figure 51: Demographics, Russia, Mortality (per 1,000 population), 2009-2016
Figure 52: Demographics, Russia, Major Causes of Mortality, 2015
Figure 53: Demographics, Russia, Infant Mortality (per 1,000 live births), 2009-2016
Figure 54: Demographics, Russia, Immunization Rate (%), 2009-2016
Figure 55: Demographics, Russia, Major Causes of Male Mortality (per 100,000 population), 2015
Figure 56: Demographics, Russia, Major Causes of Female Mortality (per 100,000 population), 2015
Figure 57: Demographics, Russia, Gender Ratio (M/F), 2009-2015
Figure 58: Demographics, Russia, Life Expectancy at Birth (years), 2009-2016
Figure 59: Demographics, Russia, Enrolment by Level of Education (‘000), 2009-2015
Figure 60: Demographics, Russia, Unemployment Rate (%), 2009-2015
Figure 61: Demographics, Russia, Distribution of Employment by Industry (%), 2015
Figure 62: Demographics, Russia, Morbidity (‘000), 2015
Figure 63: Demographics, Russia, Disability-Adjusted Life Years by Major Disease (‘000), 2012
Figure 64: Healthcare Infrastructure, Russia, Number of Hospitals (‘000), 2009-2015
Figure 65: Healthcare Infrastructure, Russia, Number of Outpatient Clinics (‘000), 2009-2015
Figure 66: Healthcare Infrastructure, Russia, Public and Private Hospitals, 2009-2015
Figure 67: Healthcare Infrastructure, Russia, Hospital Beds by Specialization (‘000), 2014
Figure 68: Healthcare Infrastructure, Russia, Diagnostic Equipment (per million population), 2009-2015
Figure 69: Healthcare Infrastructure, Russia, Hospital Beds (per 10,000 population), 2009-2015
Figure 70: Healthcare Infrastructure, Russia, Doctors (per 10,000 population), 2009-2015
Figure 71: Healthcare Infrastructure, Russia, Doctors by Specialization (‘000), 2014
Figure 72: Healthcare Infrastructure, Russia, PM2.5 (µg per m3), 2009-2015
Figure 73: Healthcare Infrastructure, Russia, CO2 Emissions (million metric tons), 2009-2015
Figure 74: Healthcare Infrastructure, Russia, Healthcare Personnel (‘000), 2014
Figure 75: Healthcare Expenditure, Russia, Healthcare Expenditure as a Percentage of GDP (%), 2009-2015
Figure 76: Healthcare Expenditure, Russia, Public-Private Share (%), 2009-2015
Figure 77: Healthcare Expenditure, Russia, R&D Expenditure as a Percentage of GDP (%), 2009-2015
Figure 78: Healthcare Market, Russia, Opportunities and Challenges, 2017
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll